Regional Changes in Brain 18 F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes

• Published in: Journal of nuclear medicine technology Vol. 46; no. 4; pp. 355 - 358
• Main Authors: Eshghi, Naghmehossadat, Garland, Linda L, Choudhary, Gagandeep, Hsu, Charles C, Eshghi, Anna, Han, James, Hamilton, Russell J, Krupinski, Elizabeth, Kuo, Phillip H
• Format: Journal Article
• Language: English
• Published: United States 01-12-2018
• Subjects: Aged; Biological Transport - radiation effects; Brain - diagnostic imaging; Brain - metabolism; Brain - physiopathology; Brain - radiation effects; Cranial Irradiation; Female; Fluorodeoxyglucose F18 - metabolism; Humans; Lung Neoplasms - diagnosis; Lung Neoplasms - drug therapy; Lung Neoplasms - metabolism; Lung Neoplasms - physiopathology; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Small Cell Lung Carcinoma - diagnostic imaging; Small Cell Lung Carcinoma - drug therapy; Small Cell Lung Carcinoma - metabolism; Small Cell Lung Carcinoma - physiopathology; lung cancer; 18F-FDG PET/CT; prophylactic cranial irradiation; cognitive impairment; small cell lung cancer; molecular imaging
• ISSN: 0091-4916; 1535-5675
• DOI: 10.2967/jnmt.118.212316

Chemotherapy followed by prophylactic cranial irradiation (PCI) is associated with increased survival in patients with small cell lung cancer but is associated with fatigue and cognitive impairment. This retrospective study evaluated regional differences in
F-FDG uptake by the brain before and after PCI. The null hypothesis was that direct toxic effects on the brain from PCI and chemotherapy are symmetric; thus, asymmetric deviations may reflect functional changes due to therapy.
Electronic medical records from 2013 to 2016 were reviewed for patients with small cell lung cancer, MRI of brain negative for metastasis, and
F-FDG PET/CT scans before and after PCI. As the standard of care, patients received first-line chemotherapy or chemoradiation to the thorax followed by PCI. The
F-FDG PET/CT scans nearest the PCI were selected. Sixteen patients met these initial criteria. Commercially available PET software was used to register and subtract the PET scans before and after PCI to obtain difference maps. Occipital and cerebellar regions were excluded from the final statistical analysis given the known high variability and misregistration. The χ
test was used to analyze the data.
Two patients had
F-FDG uptake differences only in the occipital and cerebellar regions. The software registration failed on 1 patient's scans. Therefore, 13 patients were included in the final analysis. Nine of 13 patients demonstrated significant unilateral changes in only 1 region of the brain, and 3 of 13 showed significant changes unilaterally in 2 regions. The χ
test revealed a significant unilateral regional difference on a patient level (χ
= 6.24,
= 0.025). The most commonly affected brain region was the frontal lobe.
Significantly more patients had unilateral than bilateral regional differences (both increases and decreases) in
F-FDG uptake in the brain before and after PCI. This finding suggests that differences in unilateral distribution are related to functional changes, since direct toxicity alone from PCI and chemotherapy would be symmetric. The frontal region was the most commonly affected, suggesting a potential contributing etiology for cognitive impairment and decreased executive function after therapy.